Patient Assurance Program: Meeting the Demands of Diabetes Care

Our Patient Assurance ProgramSM now includes non-insulin therapies for people managing diabetes. (Estimated Reading Time: 3 mins.)
PAP 2

One year ago, we launched our ground-breaking Patient Assurance ProgramSMto ensure eligible people with diabetes in participating plans pay no more than $25 for a 30-day supply of insulin.

Beginning July 1, 2020, we are expanding our program beyond insulin by including these diabetes therapies: DPP-4 inhibitors, GLP-1 agonists and SGLT2 inhibitors.

Along with a healthy lifestyle that includes weight management and regular physical activity, these therapies can lower blood sugar, the risk of hypoglycemia, and the need for treatment with insulin.

Proven Results

Since we implemented our Patient Assurance Program January 1, 2020, clients representing more than six million people have trusted us to help offer seamless, affordable access to insulin medication. In the first four months, the Patient Assurance Program delivered $3.7 million in direct savings to more than 40,000 members.

The Patient Assurance Program offers an average savings of 48 percent per 30-day prescription -- more than $350 per person annually. While significant, this is especially critical to those who are already financially vulnerable – and most likely to face the choice between paying for medications or other expenses.

Plans are seeing savings from improved adherence and greater formulary compliance.

How We Do It

The Patient Assurance Program protects members from high out-of-pocket costs. Participating drug manufacturers provide discounts, in addition to established rebates and existing patient discounts, to reduce member out-of-pocket costs, which are capped at $25 per 30-day prescription. Improving predictability to help ease the burden of individuals paying high out-of-pocket costs.

The program also helps increase adherence to critical diabetes medications by removing cost as a barrier to access. Best of all, the process is an automatic and seamless experience for the member.

What Matters Most

By addressing additional areas where members are exposed to high out-of-pocket medication costs, the Patient Assurance Program is delivering a new level of relief and predictability for those living with diabetes.

This groundbreaking solution moves us one step closer to helping patients focus on what matters most: their wellbeing.


Tags


Stay Informed
Subscribe to our newsletter for regular updates and the latest thinking from our experts.